Novartis AG is 21.6x more valuable than Ascendis Pharma A/S by market capitalization ($292.08 B vs $13.51 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ASND | NVS |
|---|---|---|
| Market cap | $13.51 B | $292.08 B |
| US-listed rank | #784 | #47 |
| SEC filings | 763 | 947 |
Novartis AG is 21.6x more valuable than Ascendis Pharma A/S by market capitalization ($292.08 B vs $13.51 B).
Full pages: Ascendis Pharma A/S and Novartis AG, or browse the full rankings.